To address the goals of MiND, a highly multi- and interdisciplinary team is essential. MiND represents a unique mix of people with skills and expertise in:

  • (paediatric and adult) neuropsychiatry 
  • neuropsychology 
  • neuroimaging
  • neurochemistry
  • genetics, epigenetics, genomics
  • animal models and technical assay development
  • clinical pharmacology
  • bioinformatics and biostatistics
  • ethics
  • education and training
  • valorisation and business skills
  • EU project management

Synergy within the network through exploitation of complementarities is a key issue in MiND, and the whole structure of the training programme emphasizes this interdisciplinarity. Synergy can be expected in several dimensions: (1) from bench to bedside: we find this intersectoral dimension so important that we have involved both clinically trained and basic researchers from almost all academic sites; (2) from molecule to man and population; (3) from a basic understanding of disease etiology to (first steps towards) the use of research findings in clinical diagnosis, prognosis and pharmacological and non-pharmacological treatment: our research and training programme resembles an intersectoral pipeline that can be implemented to reduce the gap between science and the clinic; (4) from academia to private sectors: placed in both sectors, our ESRs will become bridge-builders to advance science and therapy.

MiND has 12 beneficiaries and 9 partners. The consortium members have a proven track record of successful collaborations – including academic and private sector parties – showing their strong commitment to work closely together to achieve project goals related to etiology and treatment of neurodevelopmental disorders.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.